France Molecular Diagnostics Market 2017: Sales and Market Shares of Major Suppliers – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The France Molecular Diagnostics Market 2017: Sales and Market Shares of Major Suppliers Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This unique report provides France sales and market share estimates for major suppliers of molecular diagnostic products.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Competitive Assessments

– Abbott

  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Eiken
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group
  • Thermo Fisher

List of Tables

France Molecular Diagnostics Market By Major Supplier
France HIV/Hepatitis NAT Market Reagent Sales By Major Supplier

Contains 121 pages and 2 tables

Read more and order at France Molecular Diagnostics Market 2017: Sales and Market Shares of Major Suppliers

DNA Markers. Protocols, Applications, and Overviews – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The DNA Markers. Protocols, Applications, and Overviews Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

In the four decades since the discovery of DNA, molecular genetics and biotechnology have undergone a revolution in the research and application of genetic testing techniques. As a result, these fields have witnessed an explosion of both information and controversy, and the focus of public awareness of the significance of molecular biotechnology in everyday life has leaped from journal abstracts to front–page news. Molecular biotechnology provides important tools for the identification of specific nucleic acid sequences, some of them linked to important traits such as those conferring resistance to disease. Such DNA markers are used commonly in genetic research and in other applications, such as DNA fingerprinting. Researchers can use DNA markers to follow individual traits in different environments and hosts, increasing our understanding of the constitution, diversity, and evolution of genetic material.

DNA Markers: Protocols, Applications, and Overviews offers valuable new information on this rapidly growing field. This compendium of research highlights the most recently discovered DNA markers and their application to the analyses of genomes of low and high complexity, with a focus on recently developed DNA marker systems as tools for DNA fingerprinting, genome analysis, molecular systematics, taxonomy, and phylogenetic analysis. The Protocols section of the book contains detailed, step–by–step instructions on how to perform selected DNA marker experiments, providing a useful laboratory tool. Subjects covered by top specialists include:

Designed as a bench–top reference for the laboratory as well as a complete guide to the latest research, DNA Markers: Protocols, Applications, and Overviews is a vital resource for both novices and experienced practitioners involved in research in molecular genetics or biotechnology.

A global overview of DNA markers

∗ Molecular hybridization

∗ RAPD, AP–PCR, DAF and AFLP analysis

∗ Microbial Genomic fingerprinting

∗ Simple sequence repeat DNA markers

∗ Genetic BIT analysis

∗ Differential display of RNA

∗ The status of DNA fingerprinting: population databases

∗ Arbitrarily amplified DNA in ecology and evolution

Read more and order at DNA Markers. Protocols, Applications, and Overviews

Sweden Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Sweden Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report provides granular analysis of the Sweden diagnostic testing market, including volume and sales forecasts by test for the following market segments:

– Blood Banking
– Cancer
– Chemistry
– Coagulation
– Drugs of Abuse
– Endocrine
– Hematology and Flow Cytometry
– Immunoprotein
– Infectious Diseases
– Molecular Diagnostics
– TDM

Table of Contents

Market Overview

Blood Banking Market

Table 1: Blood Bank Test Volume and Reagent Sales Forecast by Test Category

Table 2: Blood Typing and Grouping Volume Forecast by Test

Table 3: Infectious Disease Screening Volume Forecast by Test

Table 4: Blood Typing and Grouping Reagent Market Forecast by Test

Table 5: Infectious Disease Screening Reagent Market Forecast by Test

Cancer Diagnostics Market

Table 6: Cancer Diagnostic Volume Forecast by Test

Table 7: Cancer Diagnostics Sales Forecast by Test

Clinical Chemistry and Immunodiagnostics Market

Table 8: Routine Chemistry Volume Forecast by Test

Table 9: Endocrine Function Volume Forecast by Test

Table 10: Tumor Markers and Special Chemistry Volume Forecast by Test

Table 11: Tumor Markers and Special Chemistry Volume Forecast by Test

Table 12: Immunoprotein Volume Forecast by Test

Table 13: TDM Volume Forecast by Test

Table 14: Drugs of Abuse Volume Forecast by Test

Table 15: Clinical Chemistry and Immunoassay Calibrator and Control Market
Forecast by Test Category

Table 16: Routine Chemistry Reagent Market Forecast by Test

Table 17: Endocrine Function Reagent Market Forecast by Test

Table 18: Tumor Markers and Special Chemistry Reagent Market Forecast by Test

Table 19: Immunoprotein Reagent Market Forecast by Test

Table 20: TDM Reagent Market Forecast by Test

Table 21: Drugs of Abuse Reagent Market Forecast by Test

Table 22: Clinical Chemistry and Immunoassay Instrument Market Forecast by
Analyzer Type

Coagulation Testing Market

Table 23: Coagulation Test Volume Forecast by Procedure

Table 24: Coagulation Diagnostics Market Forecast by Product Category

Hematology and Flow Cytometry Markets

Table 25: Hematology and Flow Cytometry Specimen Volume Forecast

Table 26: Hematology and Flow Cytometry Volume Forecast

Table 27: Hematology and Flow Cytometry Market Forecast

Table 28: Routine Hematology Volume Forecast by Test

Table 29: Flow Cytometry and Special Hematology Volume Forecast by Test

Infectious Disease Testing Market

Table 30: Infectious Disease Volume Forecast by Test

Table 31: Infectious Disease Diagnostics Market Forecast by Test

Molecular Diagnostics Market

Table 32: Molecular Diagnostic Test Volume and Sales Forecasts by Application

Table 33: Molecular Diagnostic Test Volume Forecast by Application

Table 34: Infectious Disease Volume Forecast by Test

Table 35: Molecular Diagnostics Market Forecast by Application

Table 36: Infectious Disease Diagnostics Market Forecast by Test

Contains 40 pages and 36 tables.

Read more and order at Sweden Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

Continuous Assessment of the Molecular Diagnostic Market for Clostridium Difficile (C.diff) Tests in Germany, 2016 – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Continuous Assessment of the Molecular Diagnostic Market for Clostridium Difficile (C.diff) Tests in Germany, 2016 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

Update of the 2009 started Continuous Assessment of molecular diagnostics from the end user perspective. Hospital and private laboratories have systematically been surveyed to collect information on number of labs testing, NA tests, test volumes, used platforms (separated for amplification, hybridization, detection) and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied:

Step 1: Identification of the total number of labs

Step 2: Identification of the total number of laboratories using NA technologies (in several lab units per hospital)

Step 3: Interviews with NA laboratories on NA test volume, kits, platforms and trends. A list of 39 NA tests has been provided to the labs for structured data entry. The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), Traditional and Next Generation Sequencing, TMA, LCR, NASBA, SDA, HCA, bDNA.

Read more and order at Continuous Assessment of the Molecular Diagnostic Market for Clostridium Difficile (C.diff) Tests in Germany, 2016

2017 Middle East Nucleic Acid Testing (NAT) Market: Sales Forecasts, Supplier Strategies-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The 2017 Middle East Nucleic Acid Testing (NAT) Market: Sales Forecasts, Supplier Strategies-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new 11-country report from is available by country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

– Five-year test volume and sales forecasts

– Strategic profiles of market players and start-up firms developing innovative technologies and products

– Emerging technologies

– Review of molecular diagnostic analyzers

– Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Market Segmentation Analysis

Five-year test volume and sales forecasts for major applications, including:

– Infectious Diseases- Forensic Testing
– Cancer- Paternity Testing/HLA Typing
– Genetic Diseases- Others

– Five-year test volume and sales projections for over 30 NAT assays.

– A comprehensive analysis of the sequencing market, by country and laboratory segment,
including:

– Industrial- Academic
– Government- Commercial

– Market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and suppliers in major countries.

Product/Technology Review

– Comparison of leading molecular diagnosticanalyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

– Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:

– PCR- bDNA
– SDA- NASBA
– TMA- SSSR, and others
– LCR

– Universities and research centers developing new molecular diagnostictechnologies and products.

Competitive Assessments

– Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

– Companies developing and marketing molecular diagnostics products, by test and application.

Opportunities and Strategic Recommendations

– Specific new product development opportunities with potentially significant market appeal during the next five years.

– Design criteria for new products.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Contains 1,185 pages and 98 tables

**Report Will Take 10-12 Days to Deliver after Confirmation of Payment

Read more and order at 2017 Middle East Nucleic Acid Testing (NAT) Market: Sales Forecasts, Supplier Strategies-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

2016 Slovakia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing – Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The 2016 Slovakia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing – Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights

– Five-year test volume and sales forecasts
– Feature comparison of major analyzers
– Profiles of market players and start-up firms developing innovative technologies
  and products
– Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis

– Five-year test volume and sales forecasts for major applications, including:

&nbsp &nbsp - Infectious Diseases        &nbsp &nbsp - Forensic Testing
&nbsp &nbsp - Cancer&nbsp               &nbsp                 &nbsp - Paternity Testing/HLA Typing
&nbsp &nbsp - Genetic Diseases             &nbsp &nbsp - Others

– Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review

– Comparison of leading molecular diagnostic analyzers.

– Review of molecular diagnostic technologies, test formats, detection methodologies,
  trends in testing automation and over 30 target/signal amplification methods, including:

– PCR     – bDNA
– SDA     – NASBA
– TMA    – SSSR, and others
– LCR

– Companies, universities and research centers developing new molecular-
   diagnostic technologies and products.

Competitive Assessments

– Strategic profiles of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, collaborative arrangements and
  new technologies/products in R&D.

Opportunities and Strategic Recommendations

– New product development opportunities with potentially significant market appeal
  during the next five years.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Contains 1,120 pages and 48 tables

Read more and order at 2016 Slovakia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing – Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers

2017 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The 2017 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new study contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

– Market shares of leading suppliers

– Business and technological trends in major markets

– Five-year test volume and sales forecasts

– Market shares of leading competitors

– Feature comparison of major analyzers

– Strategic profiles of leading market players and start-up firms developing innovative products

– Specific product and business opportunities for instrument and consumable suppliers.

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

France Market Overview

– Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment.

– Five-year test volume and sales projections.

Market Segmentation Analysis

– Five-year test volume and sales projections:

– Infectious Diseases – Forensic Testing

– Cancer – Paternity Testing/HLA Typing

– Genetic Diseases – Others

– A comprehensive analysis of the sequencing market by laboratory segment.

– Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.

Product/Technology Review

– Comparison of the major molecular diagnosticanalyzers.

– Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

– Worldwide listings of companies, universities and research centers developing new molecular diagnostictechnologies and products.

Competitive Assessments

– Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in RD.

– Abbott

– Affymetrix

– Agilent Technologies

– Applied Gene Technologies

– Arca Biopharma

– Beckman Coulter/Danaher

– Becton Dickinson

– Biokit

– BioMerieux

– Bio-Rad

– Biotest

– Cepheid

– CellMark Forensics/LabCorp

– Decode Genetics

– Diadexus

– Eiken

– Elitech Group

– Enzo

– Exact Sciences

– Fujirebio

– Grifols

– Hologic/Gen-Probe

– Illumina

– Kreatech/Leica

– Li-Cor Biosciences

– Life Technologies/Thermo Fisher

– Monogram Biosciences

– Myriad Genetics

– Ortho-Clinical Diagnostics

– Perkin Elmer/Caliper

– Proteome Sciences

– Qiagen

– Roche

– Scienion

– Sequenom

– Shimadzu

– Siemens

– Sierra Molecular

– Takara Bio

– Tecan Group

– Thermo Fisher

– Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

– Specific new product development opportunities with potentially significant market appeal during the next five years.

– Design criteria for new products.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Contains 407 pages

Read more and order at 2017 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

2017 Molecular Diagnostics Market: Major Suppliers Strategic Assessments – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The 2017 Molecular Diagnostics Market: Major Suppliers Strategic Assessments Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

The report presents insightful analyses of major current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 120 pages

Read more and order at 2017 Molecular Diagnostics Market: Major Suppliers Strategic Assessments

Continuous Assessment of the Molecular Diagnostic Market for HPV Genotyping Tests in UK, 2016 – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Continuous Assessment of the Molecular Diagnostic Market for HPV Genotyping Tests in UK, 2016 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

Update of the 2009 started Continuous Assessment of molecular diagnostics from the end user perspective. Hospital and private laboratories have systematically been surveyed to collect information on number of labs testing, NA tests, test volumes, used platforms (separated for amplification, hybridization, detection) and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied:

Step 1: Identification of the total number of labs

Step 2: Identification of the total number of laboratories using NA technologies (in several lab units per hospital)

Step 3: Interviews with NA laboratories on NA test volume, kits, platforms and trends. A list of 39 NA tests has been provided to the labs for structured data entry. The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), Traditional and Next Generation Sequencing, TMA, LCR, NASBA, SDA, HCA, bDNA.

Read more and order at Continuous Assessment of the Molecular Diagnostic Market for HPV Genotyping Tests in UK, 2016

2016-2020 Germany Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The 2016-2020 Germany Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new study contains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnosticsmarket during the next five years.

Report Highlights

– Business and technological trends in major markets

– Five-year test volume and sales forecasts

– Market shares of leading competitors

– Feature comparison of major analyzers

– Strategic profiles of leading market players and start-up firms developing innovative products

– Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

German Market Overview

– Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment.

– Five-year test volume and sales projections.

Market Segmentation Analysis

– Sales and market shares of leading suppliers of infectious disease molecular diagnostic
reagent kits and components.

– Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

– A comprehensive analysis of the sequencing market by country and laboratory segment.

– Detailed market segmentation analysis, including review of the market dynamics, trends,
structure, size, growth and major suppliers.

Product/Technology Review

– Comparison of leading infectious disease molecular diagnosticanalyzers.

– Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
trends in testing automation and over target/signal amplification methods.

– Worldwide listings of companies, universities and research centers developing new molecular
diagnostictechnologies and products.

Competitive Assessments

– Extensive strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, collaborative arrangements
and new technologies/products in R&ampD.

– Abbott
– Affymetrix
– Agilent Technologies
– Applied Gene Technologies
– Arca Biopharma
– Beckman Coulter/Danaher
– Becton Dickinson
– Biokit
– bioMerieux
– Bio-Rad
– Biotest
– CellMark Forensics/LabCorp
– Cepheid
– Decode Genetics
– Diadexus
– Eiken
– Elitech Group
– Enzo
– Exact Sciences
– Fujirebio
– Grifols
– Hologic/Gen-Probe
– Illumina
– Kreatech
– Li-Cor Biosciences
– Monogram Biosciences/LabCorp
– Myriad Genetics
– Ortho-Clinical Diagnostics
– Perkin Elmer/Caliper
– Proteome Sciences
– Qiagen
– Roche
– Scienion
– Sequenom
– Shimadzu
– Siemens
– Sierra Molecular
– Takara Bio
– Tecan Group
– Thermo Fisher

– Comprehensive listings of companies developing and marketing infectious disease molecular
diagnostic products, by test and application.

Opportunities and Strategic Recommendations

– Specific new product development opportunities with potentially significant market appeal
during the next five years.

– Design criteria for new products.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Contains 615 pages and 26 tables

Read more and order at 2016-2020 Germany Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies